Amyris, Inc. and Givaudan have signed a new agreement regarding cosmetic actives. The two companies have been engaged in the research and development of proprietary fragrance ingredients for several years, and the significantly expanded partnership reinforces the diversity and value of Amyris’s R&D platform and manufacturing capabilities to customers demanding high performance, cultured ingredients. During the multiyear collaboration, Amyris will use its strain engineering platform to design cosmetic active targets, and scale them up for global commercialization at Amyris’s manufacturing facility in Brotas, Brazil. The companies anticipate the launch of the target products in the coming years will demonstrate significant performance, cost and sustainability advantages over existing ingredients.
"We are very pleased with our ongoing partnership with Amyris. As our company continues to look for innovative and sustainable solutions to availability and cost challenges, we are expanding the relationship to apply Amyris’s technology to a whole new field," said Maurizio Volpi, president of Givaudan’s Fragrance Division. "This partnership will derive synergistic benefits from Givaudan’s deep understanding of the Active Beauty area and Amyris’s world class biotechnology platform."
"We are excited to be working with Givaudan to solve supply challenges and deliver sustainable innovation in cosmetic actives. We are very pleased with the Givaudan commitment to innovation and its leadership in delivering breakthrough advancements in Active Cosmetics," said John Melo, Amyris president and chief executive officer. "The collaboration validates, once again, our belief that Amyris offers its customers the fastest time to market from target identification to production of multiple tons of high quality ingredients via its disruptive approach toward meeting partners’ requirements. We are making our planet better, delivering consumers cultured ingredients that are better for them while improving our partners’ business performance."